World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 32997133

Number of visits today: 744

Number of downloads: 16182932

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Jing R, Scarfo I, Najia MA, Lummertz da Rocha E, Han A, Sanborn M, Bingham T, Kubaczka C, Jha DK, Falchetti M, Schlaeger TM, North TE, Maus MV, Daley GQ. EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activity. Cell Stem Cell 2022;29:1181-1196.e6. [PMID: 35931029 DOI: 10.1016/j.stem.2022.06.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]

For:

Jing R, Scarfo I, Najia MA, Lummertz da Rocha E, Han A, Sanborn M, Bingham T, Kubaczka C, Jha DK, Falchetti M, Schlaeger TM, North TE, Maus MV, Daley GQ. EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activity. Cell Stem Cell 2022;29:1181-1196.e6. [PMID: 35931029 DOI: 10.1016/j.stem.2022.06.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]

Number	Citing Articles
1	Hang S, Wang N, Sugimura R. T, NK, then macrophages: Recent advances and challenges in adaptive immunotherapy from human pluripotent stem cells. Differentiation 2023;130:51-7. [PMID: 36682340 DOI: 10.1016/j.diff.2023.01.001] [Reference Citation Analysis]
2	Chuprin J, Buettner H, Seedhom MO, Greiner DL, Keck JG, Ishikawa F, Shultz LD, Brehm MA. Humanized mouse models for immuno-oncology research. Nat Rev Clin Oncol 2023. [PMID: 36635480 DOI: 10.1038/s41571-022-00721-2] [Reference Citation Analysis]
3	Ditadi A, Sturgeon CM. Back to the future: lessons from development drive innovation of human pluripotent stem cell therapies. Exp Hematol 2023;117:9-14. [PMID: 36400313 DOI: 10.1016/j.exphem.2022.11.003] [Reference Citation Analysis]
4	Tsokos GC. Engineered T cells to treat lupus arrive on the scene. Nature 2022. [DOI: 10.1038/d41586-022-03563-1] [Reference Citation Analysis]
5	Ilic D, Liovic M. Industry updates from the field of stem cell research and regenerative medicine in August 2022. Regen Med 2022. [PMID: 36222015 DOI: 10.2217/rme-2022-0166] [Reference Citation Analysis]
6	Leavens KF, Alvarez-Dominguez JR, Vo LT, Russ HA, Parent AV. Stem cell-based multi-tissue platforms to model human autoimmune diabetes. Mol Metab 2022;66:101610. [PMID: 36209784 DOI: 10.1016/j.molmet.2022.101610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7	Wang Q, Guo F, Jin Y, Ma Y. Applications of human organoids in the personalized treatment for digestive diseases. Signal Transduct Target Ther 2022;7:336. [PMID: 36167824 DOI: 10.1038/s41392-022-01194-6] [Reference Citation Analysis]
8	Lavaert M, Bhandoola A. T cell development made EZ. Cell Stem Cell 2022;29:1155-6. [PMID: 35931025 DOI: 10.1016/j.stem.2022.07.003] [Reference Citation Analysis]